Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling study

[1] Yang L(2005)Estimates of cancer incidence in China for 2000 and projections for 2005 Cancer Epidemiology, Biomarkers & Prevention 14 243-250

[2] Parkin DM(2008)A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China Lancet Oncol 9 929-936

[3] Ferlay J(2011)Prevention of cervical cancer in rural China: Evaluation of HPV vaccination and primary HPV screening strategies Vaccine 29 2487-2494

[4] Li L(2006)Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study British Journal of Cancer 95 96-101

[5] Chen Y(2001)Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia Gynecol Oncol 83 439-444

[6] Qiao YL(2008)The predicted impact of vaccination on human papillomavirus infections in Australia Int J Cancer 123 1854-1863

[7] Sellors JW(2006)Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses PLoS Medicine / Public Library of Science 3 e138-536

[8] Eder PS(2004)The predicted effect of changes in cervical screening practice in the UK: results from a modelling study Br J Cancer 91 530-434

[9] Bao YP(2008)Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study Lancet Oncology 9 425-103

[10] Lim JM(2006)Carcinoma of the cervix uteri. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer International Journal of Gynaecology & Obstetrics 95 S43-18

[1] Yang L(2005)Estimates of cancer incidence in China for 2000 and projections for 2005 Cancer Epidemiology, Biomarkers & Prevention 14 243-250

[2] Parkin DM(2008)A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China Lancet Oncol 9 929-936

[3] Ferlay J(2011)Prevention of cervical cancer in rural China: Evaluation of HPV vaccination and primary HPV screening strategies Vaccine 29 2487-2494

[4] Li L(2006)Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study British Journal of Cancer 95 96-101

[5] Chen Y(2001)Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia Gynecol Oncol 83 439-444

[6] Qiao YL(2008)The predicted impact of vaccination on human papillomavirus infections in Australia Int J Cancer 123 1854-1863

[7] Sellors JW(2006)Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses PLoS Medicine / Public Library of Science 3 e138-536

[8] Eder PS(2004)The predicted effect of changes in cervical screening practice in the UK: results from a modelling study Br J Cancer 91 530-434

[9] Bao YP(2008)Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study Lancet Oncology 9 425-103

[10] Lim JM(2006)Carcinoma of the cervix uteri. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer International Journal of Gynaecology & Obstetrics 95 S43-18